Literature DB >> 33847425

TYMSOS drives the proliferation, migration, and invasion of gastric cancer cells by regulating ZNF703 via sponging miR-4739.

Yulan Gu1, Chuandan Wan2, Guoqiang Zhou3, Jinlian Zhu1, Zhiliang Shi3, Zhixiang Zhuang4.   

Abstract

Gastric cancer (GC) is a kind of malignancy originating from the epithelium of gastric mucosa. Long noncoding RNAs (lncRNAs) are tightly related to the GC progression. Herein, our research was meant to investigate a novel lncRNA thymidylate synthetase opposite strand (TYMSOS) in GC. Quantitative real-time polymerase chain reaction was used to analyze TYMSOS expression in GC cells. 5-Ethynyl-2'-deoxyuridine, flow cytometry analysis, and transwell assay detected the influence of TYMSOS on GC cell proliferation, apoptosis, migration, and invasion. Subcellular fractionation and fluorescent in situ hybridization assays determined the cellular localization of TYMSOS in GC cells. Bioinformatics programs, RNA-binding protein immunoprecipitation, RNA pull-down, and luciferase reporter assays measured the molecular interplays of TYMSOS in GC cells. In brief, TYMSOS was highly expressed in GC cells, and TYMSOS silence inhibited GC cell proliferation, migration, and invasion while elevating cell apoptosis. Functionally, TYMSOS functioned as a competing endogenous RNA to posttranscriptionally modulate GC progression. TYMSOS interacted with miR-4739 to regulate its target gene zinc finger protein 703. Collectively, our study proved the tumor-promoting role of TYMSOS in GC cells, which might offer the utility value for GC treatment.
© 2021 International Federation for Cell Biology.

Entities:  

Keywords:  TYMSOS; ZNF703; ceRNA; gastric cancer; miR-4739

Mesh:

Substances:

Year:  2021        PMID: 33847425     DOI: 10.1002/cbin.11610

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  5 in total

1.  FOXM1/lncRNA TYMSOS/miR-214-3p-Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non-Small Cell Lung Carcinoma.

Authors:  Yixiao Yuan; Xiulin Jiang; Lin Tang; Juan Wang; Dahang Zhang; William C Cho; Lincan Duan
Journal:  Front Mol Biosci       Date:  2022-02-08

2.  Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.

Authors:  Shanshan Chen; Yongchao Zhang; Xiaoyan Ding; Wei Li
Journal:  Front Genet       Date:  2022-03-21       Impact factor: 4.599

3.  Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.

Authors:  Jiarong Huang; Jinxuan Song; Xiangyu Li; Shuangfei Liu; Wentao Huang; Ziyi Shen; Yan Cheng; Shien Kou; Zhenguo Gao; Yunhong Tian; Jiani Hu
Journal:  BMC Med Genomics       Date:  2022-07-25       Impact factor: 3.622

4.  MiR-4739 inhibits the malignant behavior of esophageal squamous cell carcinoma cells via the homeobox C10/vascular endothelial growth factor A/phosphatidylinositol 3-kinase/AKT pathway.

Authors:  Kaiqin Wu; Zhenchuan Liu; Chenglai Dong; Shaorui Gu; Lei Li; Wenli Wang; Yongxin Zhou
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

5.  A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.

Authors:  Lin Chen; Zhimou Cai; Kexing Lyu; Zhiwei Cai; Wenbin Lei
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.